Loading...
 
 26510 99294
 Λεωφόρος Σταύρου Νιάρχου, 455 00 Ιωάννινα

Latest posts from
What is New in Respiratory Medicine
Facebook Group

  • Tuesday 06 Oct 2020

    Trio wins Nobel Prize in medicine for discovery of hepatitis C virus

    Air pollution causes significant morbidity and mortality in patients with inflammatory airway diseases (IAD) such as allergic rhinitis (AR), chronic r…

     
  • Tuesday 06 Oct 2020

    Emerging Complexity in the Biomarkers of Exacerbation-Prone Asthma

    During the past years, maintenance treatment with controller drugs such as inhaled steroids and, in particular, new biologics have shown clinically significant efficacy in suppressing exacerbation rates in patients with asthma (1). This has substantially changed asthma management from being a largel...

     
  • Tuesday 06 Oct 2020

    New for Journal of Asthma and online now on Taylor & Francis Online https://interasma.org/2020/10/06/new-for-journal-of-asthma-and-online-now-on-taylor-francis-online-3/

     
  • Tuesday 06 Oct 2020

    WAO Journal - Open Access: Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD)

    Air pollution causes significant morbidity and mortality in patients with inflammatory airway diseases (IAD) such as allergic rhinitis (AR), chronic r…

     
  • Tuesday 06 Oct 2020

    A team of scientists at the Population Health Research Institute, Hamilton Health Sciences, and McMaster University, Hamilton, in Ontario, Canada, revealed that increased plasma ACE2 levels in the blood could indicate a higher risk of major cardiovascular events. The study is published in the journa...

     
  • Tuesday 06 Oct 2020

    The agency made that acknowledgment briefly on its website last month but abruptly deleted it on September 21, saying the information was released in error.

     
  • Monday 05 Oct 2020

    La Belgian Respiratory Society (BeRS) est une association scientifique de médecins, d'infirmières, de physiothérapeutes et de chercheurs scientifiques qui s'intéressent aux maladies pulmonaires.

     
  • Monday 05 Oct 2020

    Severe Asthma in adults does not significantly affect the outcome of COVID-19 disease: results from the Italian Severe Asthma Registry

    Click on the article title to read more.

     
  • Monday 05 Oct 2020

    Subsolid nodules are common on chest CT and may be either benign or malignant. Their varied features, and broad differential diagnoses present management challenges. While subsolid nodules often represent lung adenocarcinomas, other possibilities are common, and influence management. Practice guidel...

     
  • Sunday 04 Oct 2020

    There may be a relationship between COVID-19 and HFpEF. SARS-CoV-2 may cause HFpEF, may unmask subclinical HFpEF, or may exacerbate existing HFpEF. Although case reports have described profound COVID-19 myocarditis leading to HFpEF, the more common manifestation in the COVID-19 era may be HFpEF related primarily to the unmasking of subclinical HFpEF and secondarily to the development of new HFpEF following infection with SARS-CoV-2.

    This Viewpoint discusses the emerging apparent association between COVID-19 and heart failure with preserved ejection fraction (HFpEF), and speculates on the pathophysiology and shared risk factors that may underlie the association and the possibility that SARS-CoV-2 infection may unmask or...

     
  • Monday 05 Oct 2020

    How far have we come in our understanding and use of airway clearance techniques (ACTs) in bronchiectasis? In Chest, hot off the press!

    How far have we come in our understanding and use of airway clearance techniques (ACTs) in bronchiectasis? Cough and sputum production are defining symptoms in bronchiectasis.1,2 Because the pathophysiology of bronchiectasis leads to impaired mucociliary clearance it makes theoretical sense to enhan...

     
  • Monday 05 Oct 2020

    A second wave pandemic constitutes an imminent threat to society, with a potentially immense toll in terms of human lives and a devastating economic impact. This temporal playbook of the second wave pandemic can be used by governments, financial markets, the industries and individual citizens, to efficiently time, prepare and implement local and global measures.

    A second wave pandemic constitutes an imminent threat to society, with a potentially immense toll in terms of human lives and a devastating economic impact. We employ the epidemic Renormalisation Group (eRG) approach to pandemics, together with the first wave data for COVID-19, to efficiently simula...

     
  • Monday 05 Oct 2020

    During the first wave of pandemic COVID-19, SD measures resulted in limiting the burden of the COVID-19 outbreak and prevention of the healthcare system becoming overwhelmed. In the present study, the COVID-19 epidemic in Greece has been reproduced using a mathematical transmission model. To evaluate the impact of interventions, a counterfactual model, without the SD measures, has been used, and this has been compared with the actual model. The analysis highlights that the SD interventions took place sufficiently early in the outbreak and were highly successful as they managed to keep the number of deaths and need for ICU beds at low levels and within the capacity of the national healthcare systeM.

    The aim of the study was to assess the impact of social distancing interventions in Greece and to examine what would have happened if those interventi…

     
  • Monday 05 Oct 2020

    Today's COVID-19 highlights from Physician's First Watch: A look at the treatments President Trump has received, a plan for who gets vaccinated first (and second and third), the safety of face masks even in people with lung impairment & more: https://jwat.ch/2SshpDe #COVID19 #SARSCoV2

     
  • Monday 05 Oct 2020

    President Donald Trump acquired COVID-19 despite the fact that he and those around him are tested often. How did this happen and what does it mean for a strategy of frequent testing for COVID-19 control? Infectious disease specialist Dr. Paul Sax takes a closer look: https://jwat.ch/3cZsAww #COVID19 #SARSCoV2

     
  • Sunday 04 Oct 2020

    Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study

    Patients with ILD are at increased risk of death from COVID-19, particularly those with poor lung function and obesity. Stringent precautions should be taken to avoid COVID-19 in patients with ILD.

     
  • Sunday 04 Oct 2020

    Clinical phenotypes of patients hospitalized for an asthma exacerbation: prognostic implications - The Journal of Allergy and Clinical Immunology: In Practice https://buff.ly/3l7QQ2j

    Hospitalization due to acute asthma exacerbation (AE) is a highly detrimental situation requiring critical management to prevent further deterioration, including mechanical ventilation, intensive care unit (ICU) admission, and death. However, patients hospitalized for AEs are highly heterogeneous an...

     
  • Sunday 04 Oct 2020

    Telehealth appears useful to fill in the void for home-ventilated patients to maintain the much-needed connectivity with their healthcare team during the #COVID19 pandemic buff.ly/33tWK8b

    The evolution of positive airway pressure (PAP) devices since their introduction by Colin Sullivan in 1980 has witnessed growing evidence supporting their use for medical conditions associated with chronic ventilatory failure. The emergence of PAP devices also resulted in a higher number of patients...

     
  • Sunday 04 Oct 2020

    Clinical criteria for COVID-19-associated hyperinflammatory syndrome

    We proposed and validated criteria for hyperinflammation in COVID-19. This hyperinflammatory state, cHIS, is commonly associated with progression to mechanical ventilation and death. External validation is needed. The cHIS scale might be helpful in defining target populations for trials and immunomo...

     
  • Saturday 03 Oct 2020

    Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.

    Six-criterion additive scale for COVID-19-associated hyperinflammatory syndrome (cHIS): fever, macrophage activation (hyperferritinaemia), haematological dysfunction (neutrophil to lymphocyte ratio), hepatic injury (lactate dehydrogenase or asparate aminotransferase), coagulopathy (D-dimer), and cytokinaemia (C-reactive protein, interleukin-6, or triglycerides). This hyperinflammatory state is commonly associated with progression to mechanical ventilation and death. The cHIS scale might be helpful in defining target populations for trials and immunomodulatory therapies.

     
317 Αντικείμενα. Σελίδα 4/16
1 2 3 4 5 6 7 8 9 10
 
Developed by LogicOne